Association of COVID-19 with skin diseases and relevant biologics: a cross-sectional study using nationwide claim data in South Korea.

Published in: The British journal of dermatology (2020)

Underlying skin diseases did not appear to increase susceptibility to COVID-19 or mortality from COVID-19. Considering the risks and benefits, biologics for dermatological conditions might be continuously used during the COVID-19 pandemic.

Keyphrases

coronavirus disease
sars cov
soft tissue
risk factors
physical activity
wound healing
type diabetes
electronic health record
big data
coronary artery disease
artificial intelligence
climate change